ANAM™ Validity & Reliabilty

ANAM's™ use in DoD laboratories, as well as other research sites, has led to an extensive volume of scientific studies in neurocognitive assessment.

  • ANAM tests have been studied using factor analysis and structural modeling techniques to examine factor structure.
  • ANAM has demonstrated the capability to measure the same underlying constructs as traditional, well-validated neuropsychological testing.
  • ANAM provides a consistent measure of cognitive functioning across many samples of healthy and clinical populations.  ANAM's use in DoD laboratories and other research sites has led to an extensive volume of scientific studies across many applications, affirming its validity for neurocognitive assessment in:
    • Alzheimer's Disease
    • Athlete Health and Fitness
    • Dementia
    • Cancer
    • Fibromyalgia
    • Lupus
    • Migraine headaches
    • Multiple Sclerosis
    • Parkinson's Disease
    • Radiation Exposure
    • Traumatic Brain Injury (TBI)
    • ...and other conditions.

Cognitive Evaluation for Disease States/Interventions

ANAM has been used by clinicians to measure cognitive change in medication trials and interventions including:

  • cognitive side effects of medications.
  • cognitive enhancing properties of various medications.
  • benefits of various treatments and interventions on cognitive functioning.

 

 

ANAM software includes intellectual property exclusively licensed from the U.S. Army for commercialization.

<back / top